SCHEMBL16139269

SCHEMBL16139269

Cc1cc(C)c2cc(C)c(N3CCN(C(=O)c4ccccc4)CC3)nc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 6/20 0.64
▸ MEN1 O00255 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ POLB P06746 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ SMO Q99835 3/20 0.52
▸ NTSR1 P30989 1/20 0.50
▸ MAPT P10636 1/20 0.49
▸ MGLL Q99685 1/20 0.48
▸ CDK1 P06493 1/20 0.48
▸ IGF1R P08069 1/20 0.48
▸ FGFR1 P11362 1/20 0.48
▸ BRAF P15056 1/20 0.48
▸ FGFR2 P21802 1/20 0.48
▸ FGFR4 P22455 1/20 0.48
▸ FGFR3 P22607 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16141421 0.91 CFTR (0.77) CFTRMEN1KMT2AL3MBTL1POLB
SCHEMBL16141422 0.88 CFTR (0.79) CFTRMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL14235251 0.78 CFTR (1.00) CFTRMEN1KMT2AL3MBTL1HTT
SCHEMBL14235252 0.77 CFTR (1.00) CFTRMEN1KMT2AL3MBTL1HTT
SCHEMBL14235359 0.76 CFTR (1.00) CFTRMEN1KMT2AL3MBTL1HTT
SCHEMBL14235249 0.75 CFTR (1.00) CFTRMEN1KMT2AL3MBTL1HTT
SCHEMBL14406254 0.74 MEN1 (0.58) CFTRMEN1KMT2AL3MBTL1POLB
SCHEMBL14235250 0.73 CFTR (1.00) CFTRMEN1KMT2AL3MBTL1HTT
SCHEMBL19446822 0.73 ALDH1A1 (0.56) MEN1KMT2AL3MBTL1POLBHTT
SCHEMBL14235358 0.72 CFTR (1.00) CFTRMEN1KMT2AL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073863-B2 Cyanoquinoline compounds having activity in correcting mutant-CFTR processing and increasing ion transport and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-07-07 — — US disclosed
US-20140296215-A1 Cyanoquinoline Compounds Having Activity in Correcting Mutant-Cftr Processing and Increasing Ion Transport and Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296215-A1 Cyanoquinoline Compounds Having Activity in Correcting Mutant-Cftr Processing and Increasing Ion Transport and Uses Thereof CFTR, SLC47A1, SLC47A2 CFTR 1/4885MEN1 3428/4885KMT2A 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback